According to the data, up to 40% of high risk patients in non-albuminuric/ proteinuric DKD patients are unidentified by current detection method, and often causes delayed on treatment intervention. Human uPTM DNlite-IVD103 ELISA test provides higher sensitivity on predicting eGFR progressive decline (kidney function loss), and it can easily identify early risk of DKD progression (eGFR progressive decline).
Human uPTM DNlite-IVD103 ELISA test can simply performed in hospitals and clinical labora